Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Beam

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Blind woman thanks strangers who helped her land a job at her old college

£1,408 was raised in 11 days through donations from over 50 members of the public.

The Independent UK

Who's liable if you're injured or killed riding an e-scooter?

The rental e-scooter craze is sweeping the globe, with millions of the vehicles dotting pavements in more than 600 cities. Studies predict there will be 4.6 million shared e-scooters in operation worldwide by 2024.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Solution or hazard? Australia’s e-scooter debate gains speed, but the rules are a mess

With rising petrol prices and environmental concerns, e-scooters are quickly growing in popularity. But as legislation lags, are they safe?

The Guardian - AU

Could The Next CRISPR From Verve, Beam Signal The End To High Cholesterol?

Verve Therapeutics said Tuesday it edited the genes of someone with high cholesterol. The first-ever move could push VERV stock higher.

Investors Business Daily

Business Life: charity initiatives and award wins in the North East

Our round-up of stories this week includes Ocado Retail, Hay &Kilner, the North East BIC and durhamlane

Birmingham Post

BMO Capital Says Risk/Reward For This Gene Stock Assumes Clinical Success

BMO Capital initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Market Perform rating and a price target of 41. BMO writes that it appreciates the high potential of Beam's next-generation editing approach, but clinical validation is yet to be established. Preclinical base editing data point to a favorable benefit/risk profile. Also Read: Pfizer, Beam…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Cyclists ride high ahead of Lake e-bike launch

A start date has not been set, but organisers plan to have them ready to use by the end of this month.

Newcastle Herald

500 electric bikes to be rolled out in Lake Macquarie trial

The e-bike trial is being driven by Lake Macquarie City's economic arm Dantia

Newcastle Herald

A timeline of developments across Sunderland - what's changed and what's coming?

There have been plenty of new builds across Wearside in recent years for locals and visitors alike to make the most of, with many more coming in the pipeline.

Chronicle Live

5 Beaten-Down Biotech Stocks Cathie Wood Loves

Renowned investor Cathie Wood of ARK Invest is known for her eye for stocks with enormous upside potential. Despite recent macro headwinds, the biotech industry is expected to grow tremendously in 2022, supported by strong demand for healthcare and medical products and increasing investments in R&D. Given these factors, Wall…

StockNews.com

Swords youngster gets to meet Ireland soccer heroes as he pilots new FAI BEAM Robot

Simon Smyth got to chat with Ireland captain Seamus Coleman and strikers Callum Robinson and Chiedozie Ogbene at the FAI National Training Centre - from the comfort of home.

Dublin Live

Where you'll soon be able to ride e-scooters in Canberra

A further expansion of the e-scooter zones will take place in the second half of 2022.

The Canberra Times

1 2 3

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Sunderland City Council

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.